MDxHealth SA revised revenue guidance for the fiscal year 2022. For the period, the company expects revenue guidance to be $36.5 million - $37.5 million from $40 million - $42 million.
MDxHealth SA Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+1.54% | 42.59B | |
+8.30% | 40.65B | |
+48.88% | 40.57B | |
-11.96% | 26.77B | |
+8.05% | 24.81B | |
-24.18% | 18.17B | |
+28.22% | 12.05B | |
-3.05% | 11.7B | |
+7.55% | 11.1B |